{"name":"Synlogic","slug":"synlogic","ticker":"SYBX","exchange":"NASDAQ","domain":"synlogictx.com","description":"AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.","hq":"Cambridge, MA","founded":0,"employees":"","ceo":"N/A (Board-managed)","sector":"Synthetic Biology / Living Medicines","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$15M","metrics":{"revenue":5000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":43000,"netIncome":-1005000,"cash":14668000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"trial","headline":"Synlogic Announces Positive Topline Results from Phase 1 Clinical Trial of SYNB1353","summary":"Synlogic announced positive topline results from a Phase 1 clinical trial of SYNB1353, its lead candidate for the treatment of phenylketonuria (PKU). The trial met its primary endpoint, demonstrating a statistically significant reduction in phenylalanine levels.","drugName":"SYNB1353","sentiment":"positive"},{"date":"2023-11-14","type":"deal","headline":"Synlogic Enters into Collaboration and License Agreement with Pfizer","summary":"Synlogic entered into a collaboration and license agreement with Pfizer to develop and commercialize its synthetic biology platform for the treatment of rare genetic diseases.","drugName":"N/A","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQaHJVQTBoOHo4N2tRTjltUVpHSzdNNng2YjVDNDZPU0UzZVdyel9JSDlQNldIX0wwVHBjLUdsRF9ac3NHV0lLVElyTWV5RHozbDNvN0twYS15bkROd3NjXzZnMmhpWmwySkcyc2dsSWliM2hZNVRaTzUzZjRsc3hldndpM1RQRTZXR09kS0pjMTFPSl9hQnRqUHNMbzB1eFdnb1VNVlFZZFl5SlRmTE1CeUNwMnZWdGNHbzF4M01MOA?oc=5","date":"2026-04-06","type":"pipeline","source":"Stock Titan","summary":"Investor group offers $0.64 cash for Synlogic (SYBX) in take-private move - Stock Titan","headline":"Investor group offers $0.64 cash for Synlogic (SYBX) in take-private move","sentiment":"neutral"},{"date":"2026-03-12","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNbE5VSk8xdHpFUTIyblU4OEJSVll1X0RfQWRlTXFlVDhvLXkxQTV5ZnlMcTRIVV9haVBfMU9Fb0o4OVRhTWNDa1RGY2Z1aVYtTjhCQ0JXMU04emphQmJqVUJiWUJDbkVNV1FoNTBjcXVScWVpRVk4M2pHWU5DUWoyMnk3Ny04UDVEcVVaZjFiSTAzSGhxQmtLYWJSVmRYMDJ3bFhv?oc=5","date":"2026-01-20","type":"pipeline","source":"Stock Titan","summary":"Synlogic (NASDAQ: SYBX) ends Nasdaq listing bid, plans OTC trading - Stock Titan","headline":"Synlogic (NASDAQ: SYBX) ends Nasdaq listing bid, plans OTC trading","sentiment":"neutral"},{"date":"2026-01-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-12-16","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-26","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2025-11-13","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-18","type":"pipeline","source":"simplywall.st","summary":"Companies Like Synlogic (NASDAQ:SYBX) Are In A Position To Invest In Growth - simplywall.st","headline":"Companies Like Synlogic (NASDAQ:SYBX) Are In A Position To Invest In Growth","sentiment":"neutral"},{"date":"2025-08-07","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-05-08","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOUGp1LVhhQ1NYTkZhV3dWSlVBYm5ZM2p5Z01ybC1FRUhNaHZSY0QzZjFOeHlWWUZ4dkFHcl83UTVwWFRoOTVTSzZPdTd1UkpYVHhycVhBODBSWTRiQWk5MWlCNVUzWVNKRVhVQUV1Ymcwd1dfZkxrS1NRZzhZSjFiamM3QnRPOVBveUE?oc=5","date":"2023-05-09","type":"regulatory","source":"Seeking Alpha","summary":"Synlogic stock climbs on FDA orphan drug status (NASDAQ:SYBX) - Seeking Alpha","headline":"Synlogic stock climbs on FDA orphan drug status (NASDAQ:SYBX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPZlFPNGtlbEcyamRUallfRndVVmR3YUMxS0czYjlsbk11QkhOenY2RldBelhyM1hWU2pHdEdYcVJ2TXVlbjNESG15ZUV0emVFc3g5WmpIaDM1TDI2LW5vaGRDMDVwRXB4clpvWEw5SVlhaTBrb0p1QS1IbmE5WE1uaFJ4SWs2c0UxZHZvWDAwVUxsUURILUJWR0NRaEh0Qko2UGtLcFZmVThQLVQ1RHpPczhQLU1HNGs?oc=5","date":"2020-09-14","type":"pipeline","source":"PR Newswire","summary":"Synlogic Appoints David Hava, Ph.D., as Chief Scientific Officer - PR Newswire","headline":"Synlogic Appoints David Hava, Ph.D., as Chief Scientific Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBteDZZTmhDb200NldHQTVmcTZ3bEJxd2pqWTI2cnJlOWt2a1JGeXpUT3l2STVVM0JlTHN5ZU5pbEFLdG9nSW1FSXNDRnhUTFl1RjZ5WUttQnotUmg4S3lBaFFPdUhDVFFrMXBhUzQwcnBFeW9CNEFJZXEzcFhxcEU?oc=5","date":"2020-07-31","type":"pipeline","source":"citybiz","summary":"Synlogic Promotes Antoine Awad to COO - citybiz","headline":"Synlogic Promotes Antoine Awad to COO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxNeGlDclRQY3Z1Y1ZwbEpoaGtQOHY3SVlOMlJ3NENySFJIMWRrT0tuTTRoSmlySGxteU93RWMzN25icXhMenlQS2MtOVllVGptVkNqNVBXRm5fdGI1RVRIcGdIVHp0ZW9vNXZRX2hjRHhtZVdkS2R4WWF6ajZiRmgtVENqblg5bk42cklsSkY2QU8?oc=5","date":"2019-05-23","type":"deal","source":"Yahoo Finance","summary":"Synlogic (SYBX) Enters Cancer Collaboration with Roche - Yahoo Finance","headline":"Synlogic (SYBX) Enters Cancer Collaboration with Roche","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBqbWhNSkx3aDVPRXBnV2x1Y1U1amN4YXlXV2VodHpFX1lJUnd2OE1pdEQ3UzdOZnU0R3VLQWJra0s1Uk1saDY4NFdHNTdDdF9odUE?oc=5","date":"2019-03-10","type":"pipeline","source":"Yahoo Finance Australia","summary":"Synlogic, Inc. (SYBX) stock price, news, quote and history - Yahoo Finance Australia","headline":"Synlogic, Inc. (SYBX) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Editas Medicine","CRISPR Therapeutics","Intellia Therapeutics"],"therapeuticFocus":["Metabolic Disorders","Rare Genetic Diseases"],"financials":{"source":"sec_edgar","revenue":0,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":0,"period":"2025-12-31"},{"value":8000,"period":"2024-12-31"},{"value":3371000,"period":"2023-12-31"},{"value":1180000,"period":"2022-12-31"},{"value":1754000,"period":"2021-12-31"},{"value":545000,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":43000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-1005000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":14668000,"cashHistory":[],"totalAssets":15447000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":null}